Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06425003
Status:
COMPLETED
Last Update Posted:
2024-06-24
First Post:
2024-05-06
Brief Title:
Study of 14C ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration
Sponsor:
Calico Life Sciences LLC
Organization:
Calico Life Sciences LLC
Study Overview
Official Title:
Mass Balance Study of 14C ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate mass balance pharmacokinetics and safety of 14C ABBV-CLS-7262 in healthy male volunteers following administration of a single oral dose
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None